Answer:
A. Report this as a Serious Adverse Event (SAE).
Explanation:
When undergoing a trial using a medical product, subjects might sometimes experience certain negative effects referred to as Serious Adverse Events. These effects might range from, hospitalization, death, congenital defects, disabilities, etc.
If the medical personnel suspects that the negative effect was as a result of the medical product used, it becomes necessary to report such as a Serious Adverse Event. So, in the scenario above where a participant suddenly misses participation and his death becomes known through public records, suspicions might be that the death was a serious adverse event caused by the study.
Answer:
d. The drug will stop protaglandin production and end inflammation caused by osteoarthritis, thereby slowing the effects of aging
Answer:Susan most likely have DIABETES MELLITUS.
Explanation: Diabetes Mellitus is common endocrine disorder accompanied by varying degrees of disruption of carbohydrate, protein and fat metabolism.
Diabetes Mellitus is caused by absence of, relative deficiency of/ resistance to the hormone INSULIN. It's signs and symptoms includes hyperglycemia ( increased blood sugar level), increased thirst( polydipsia), glucose in the urine(glucosuria), increased urination(polyuria), weight loss without trying, ketosis and ketoacidosis.
Causes include; Obesity, Sedentary lifestyle, Increasing age,genetic factors, autoimmune reactions, environmental factors including viral infections.
Answer:
Explanation:
48-year-old woman scheduled for a mastectomy who is complaining of chills.
